XML 37 R26.htm IDEA: XBRL DOCUMENT v3.25.3
EQUITY (Tables)
9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
SCHEDULE OF ISSUANCE OF WARRANTS TO PURCHASE COMMON STOCK

 

  

Number of

underlying
Common stock

   Exercise price   Expiration date
Series F Warrants   14,815   $7.4250   October 16, 2025
Series G Warrants   1,092,344   $10.230   February 8, 2026
Series J Warrants   12,914,086   $1.3827   *
Series K Warrants   12,914,078   $1.3827   *
Total Warrants   26,935,323         

 

*

The Series J Warrants and Series K Warrants have a term of the earlier of (i) May 15, 2028 and (ii) (A) in the case of the Series J Warrants, 20 trading days following the Company’s announcement of receipt of FDA approval for the SwitchGuard and CGuard Prime 80 and (B) in the case on the Series K Warrants, 20 trading days following the end of the fourth fiscal quarter after the fiscal quarter in which the first commercial sales of the CGuard Carotid Stent System in the United States begins.